Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharynx Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07101744
What this trial is testing

Iparomlimab and Tuvonralimab Combined With Nimotuzumab in Recurrent or Metastatic NPC After First-line Treatment Failure: A Single-arm Phase IIa Clinical Trial

Who this might be right for
Nasopharyngeal Carcinoma (NPC)First-line Treatment Failure Nasopharyngeal Carcinoma
Sun Yat-sen University 41
Not applicableNot Yet RecruitingNCT07413627
What this trial is testing

A Study Evaluating the Contribution of Non-Coplanar Beam Arrangement in Reducing Toxicity in Radiotherapy for Upper Aerodigestive Tract Cancers

Who this might be right for
Squamous Cell Carcinoma of the Oral Cavity and Oropharynx
Centre Georges Francois Leclerc 70
Testing effectiveness (Phase 2)UnknownNCT05341193
What this trial is testing

PD-1 Blockade and Bevacizumab Replace Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 32
Large-scale testing (Phase 3)Active Not RecruitingNCT04590963
What this trial is testing

Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
AstraZeneca 370
Large-scale testing (Phase 3)Looking for participantsNCT07340515
What this trial is testing

Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Man Hu 300
Not applicableStudy completedNCT00310115
What this trial is testing

Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
M.D. Anderson Cancer Center 469
Not applicableUnknownNCT06523933
What this trial is testing

Distribution of Bacteria in OME After Radiotherapy For NPC.

Who this might be right for
Otitis Media EffusionNasopharyngeal Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 234
Early research (Phase 1)Looking for participantsNCT06886347
What this trial is testing

Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Metastatic Nasopharyngeal Carcinoma
Chen Xiaozhong 47
Large-scale testing (Phase 3)Looking for participantsNCT03907826
What this trial is testing

PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients

Who this might be right for
Recurrent Nasopharyngeal Carcinoma
Sun Yat-sen University 212
Not applicableStudy completedNCT01084733
What this trial is testing

Nicotine Levels With Response Rates to Radiation Alone or With Chemo In Head & Neck Cancer

Who this might be right for
Larynx CancerLip CancerOral Cavity Cancer+2 more
Mahesh Kudrimoti 115
Large-scale testing (Phase 3)Temporarily pausedNCT05050162
What this trial is testing

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

Who this might be right for
Advanced Head and Neck Squamous Cell CarcinomaAdvanced Hypopharyngeal Squamous Cell CarcinomaAdvanced Laryngeal Squamous Cell Carcinoma+7 more
NRG Oncology 1,714
Testing effectiveness (Phase 2)WithdrawnNCT05290194
What this trial is testing

Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal Carcinoma

Who this might be right for
RadiotherapyPD-1 InhibitorCapecitabine+1 more
Fifth Affiliated Hospital, Sun Yat-Sen University
Large-scale testing (Phase 3)Looking for participantsNCT04778956
What this trial is testing

Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaPD-1Surgery
Sun Yat-sen University 218
Testing effectiveness (Phase 2)Ended earlyNCT02917629
What this trial is testing

ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment

Who this might be right for
Oral Cavity NeoplasmOropharyngeal NeoplasmStage 0 Oral Cavity Squamous Cell Carcinoma American Joint Committee on Cancer (AJCC) v6 and v7+11 more
National Cancer Institute (NCI) 6
Not applicableStudy completedNCT04952922
What this trial is testing

Changes to Function and Quality of Life and Patient Experience for Patients Undergoing Treatments for Recurrent Oropharyngeal Cancer

Who this might be right for
Recurrent Oropharynx Carcinoma
Royal Marsden NHS Foundation Trust 25
Testing effectiveness (Phase 2)UnknownNCT05898256
What this trial is testing

Cadonilimab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaImmune Checkpoint Inhibitors
Guangxi Medical University 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07418034
What this trial is testing

A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CancerHead and Neck Squamous Cell Carcinoma+11 more
University of Maryland, Baltimore 132
Not applicableUnknownNCT05449184
What this trial is testing

A Prospective, Randomized, Controlled Clinical Study of BET Combined With Tympanostomy Tube Insertion in the Treatment of Intractable OME After Radiotherapy for NPC

Who this might be right for
Otitis Media With Effusion After Nasopharyngeal Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 208
Not applicableNot Yet RecruitingNCT07036211
What this trial is testing

Transmission of Oncogenic HPV Infection Among Families

Who this might be right for
Human Papilloma Virus (HPV)Cervical CarcinomaOropharyngeal Carcinoma+3 more
Tampere University Hospital 700
Large-scale testing (Phase 3)Not Yet RecruitingNCT07783321
What this trial is testing

Anti-PD-1 Antibody With or Without BL-B01D1 as Maintenance Therapy Following Anti-PD-1 Antibody Plus Chemotherapy for the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma (PANKU-NPC02)

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sichuan Baili Pharmaceutical Co., Ltd. 404
Next Page